Sec Form 4 Filing - Tran Hai @ SOC Telemed, Inc. - 2020-10-30

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Tran Hai
2. Issuer Name and Ticker or Trading Symbol
SOC Telemed, Inc. [ TLMD]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
CFO and COO
(Last) (First) (Middle)
C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100
3. Date of Earliest Transaction (MM/DD/YY)
10/30/2020
(Street)
RESTON, VA20190
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/30/2020 A 337,112 A 337,112 D
Common Stock 10/30/2020 A 120,954 A 458,066 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $ 2.48 10/30/2020 A 395,578 ( 3 ) 06/07/2028 Common Stock 395,578 ( 4 ) 395,578 D
Stock Options $ 3.71 10/30/2020 A 169,533 ( 3 ) 06/07/2028 Common Stock 169,533 ( 5 ) 169,533 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Tran Hai
C/O SOC TELEMED, INC.
1768 BUSINESS CENTER DRIVE, SUITE 100
RESTON, VA20190
CFO and COO
Signatures
/s/ Eunice Kim, as Attorney-in-Fact 11/03/2020
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Received in connection with the Issuer's business combination (the "Business Combination") with Specialists On Call, Inc. ("Legacy SOC Telemed") in accordance with the terms of the Agreement and Plan of Merger dated as of July 29, 2020, among the Issuer (f/k/a Healthcare Merger Corp.), Sabre Merger Sub I, Inc., Sabre Merger Sub II, LLC and Legacy SOC Telemed, in exchange for options to acquire 1,955,129 shares of common stock of Legacy SOC Telemed for $1.00 per share.
( 2 )Received in connection with the Business Combination in exchange for options to acquire 837,913 shares of common stock of Legacy SOC Telemed for $1.50 per share.
( 3 )The stock option will vest and become exercisable in full on November 15, 2021, subject to the continuous service of the Reporting Person on such vesting date.
( 4 )Received in connection with the Business Combination in exchange for options to acquire 977,565 shares of common stock of Legacy SOC Telemed for $1.00 per share.
( 5 )Received in connection with the Business Combination in exchange for options to acquire 418,956 shares of common stock of Legacy SOC Telemed for $1.50 per share.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.